Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 24, 2026

CRWV vs. MSFT: Which AI Infrastructure Stock is the Better Buy?

View original at finance.yahoo.com
CRWV vs. MSFT: Which AI Infrastructure Stock is the Better Buy? Behind every generative AI model and autonomous system is massive compute infrastructure, especially data centers full of GPUs that train and serve models…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Spending on AI data centers and accelerated computing is surging, creating a multitrillion-dollar opportunity

    80% confidence
  • Active power is expected to exceed 850 MW by year-end

    80% confidence
  • The Core Scientific acquisition decision does not affect its growth outlook

    80% confidence
  • MSFT remains the stronger long-term buy, with AI monetization through Azure and Copilot, massive RPO visibility and diversified cash flows

    80% confidence
  • Management remains upbeat about ongoing growth across commercial and enterprise segments, driven by global capacity buildout and multiple revenue pillars

    80% confidence
  • In terms of valuation, CRWV seems to be a better pick at the moment

    80% confidence
  • Management remains confident in its ability to meet long-term demand, scale capacity and strengthen its position in AI cloud as new offerings, partnerships and federal deals ramp

    80% confidence
  • CRWV looks better positioned for near-term outperformance because we are in the AI capacity-deployment phase

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com